Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rifampicin + Isoniazid + Pyrazinamide
- Therapeutic area
- Anti-infectives
- Drug class
- Antimycobacterials
- ATC
- J04AM
- Strength
- 60 mg + 30 mg + 150 mg
- Dosage form
- Tablet
- Pack
- 100’s
- Registration no.
- 069167
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What RIFIN-P PEDIATRIC (Rifampicin + Isoniazid + Pyrazinamide) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Rifampicin + Isoniazid + Pyrazinamide is right for you and the dose.
- Tuberculosis (TB): the same first-line medicines combined in one tablet to reduce the number of tablets
About RIFIN-P PEDIATRIC 60 mg + 30 mg + 150 mg tablet
RIFIN-P PEDIATRIC 60 mg + 30 mg + 150 mg tablet contains Rifampicin + Isoniazid + Pyrazinamide 60 mg + 30 mg + 150 mg. It is registered with DRAP by Pacific Pharmaceutical Ltd (registration no. 069167). Its official price is PKR 1,368.53 for a pack of 100’s, about PKR 13.69 per tablet. This price has applied since 1 July 2024. 1 other brand of Rifampicin + Isoniazid + Pyrazinamide 60 mg + 30 mg + 150 mg (tablet) is registered in Pakistan. Compare all brands and prices →
All 1 other brands of Rifampicin + Isoniazid + Pyrazinamide 60 mg + 30 mg + 150 mg tablet in Pakistan
These 1 brands are alternatives (substitutes) to RIFIN-P PEDIATRIC: each contains Rifampicin + Isoniazid + Pyrazinamide 60 mg + 30 mg + 150 mg tablet. Ask your doctor or pharmacist before you switch brands.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Pyratar Tabs | UNEXOLABS (PVT) LTD | 1's | PKR 8.36 | PKR 8.36 / tablet |
See every strength and form of Rifampicin + Isoniazid + Pyrazinamide →
How old is this price? It was fixed on 1 July 2024 and has not changed since — that is 2 years ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for RIFIN-P PEDIATRIC, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Pacific Pharmaceutical Ltd, Lahore
- DRAP registration
- 069167
- Phone
- +92 42 35975291-93
- info@pacificpharmaceuticals.com
- Website
- https://pacificpharmaceuticals.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (100’s). Current price PKR 1,368.53, effective 1 Jul 2024.
Cite this price history
MedInfoBase. RIFIN-P PEDIATRIC 60 mg + 30 mg + 150 mg, 100’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifin-p-pediatric-60-mg-30-mg-150-mg-069167-100s-pacific-pharmaceutical-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,368.53 | 2024-07-01 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 069167Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.